What is the anteroposterior diameter (APD) measurement classification on ultrasound in children?

APD Measurement Classification in Ultrasound for Children

The anteroposterior diameter (APD) of the renal pelvis is measured in the transverse plane at the kidney's midpoint, with established normal limits of <4 mm before 28 weeks gestation and <7 mm after 28 weeks gestation; postnatally, an APD <10 mm is generally considered normal in children. 1

Classification Systems

APD Measurement Thresholds

The APD system provides objective measurements with the following clinical significance 1:

Antenatal (Prenatal) Cutoffs:

• Normal: <4 mm (before 28 weeks gestation)
• Normal: <7 mm (after 28 weeks gestation)
• Predictive of UPJ obstruction requiring surgery: ≥15 mm in third trimester

Postnatal Cutoffs:

• Normal: <10 mm 2
• Grade 1: <10 mm (typically resolves spontaneously)
• Grade 2: 10-15 mm (intermediate risk)
• Grade 3: 15-20 mm (higher risk)
• Grade 4: >20 mm (likely pathologic)

Research confirms that postnatal APD measurements are superior to antenatal measurements for predicting surgical intervention 1. An APD cutoff of 15 mm postnatally has been identified as predictive of need for surgical intervention 1.

UTD (Urinary Tract Dilation) Classification System

The 2014 multidisciplinary consensus established the UTD grading system to unify terminology across specialties 1. This system integrates APD with other collecting system findings and is now the preferred comprehensive approach:

UTD P1 (Low Risk):

• APD <10 mm (prenatal) or <15 mm (postnatal)
• Central renal pelvis dilation only
• 90-100% resolve by age 4 years 1

UTD P2 (Intermediate Risk):

• APD 10-15 mm (prenatal) or ≥15 mm (postnatal)
• Peripheral calyceal dilation present

UTD P3 (High Risk):

• Severe APD measurements
• Parenchymal abnormalities
• Ureteral dilation ≥7 mm (particularly significant for UTI risk) 1

Clinical Application Algorithm

For initial postnatal evaluation:

1. Measure APD in transverse plane at kidney midpoint - this is operator-dependent but objective 1

2. Assess additional features:

   • Calyceal dilation (focal vs. diffuse)
   • Parenchymal thickness/integrity
   • Ureteral dilation
   • Bladder abnormalities

3. Risk stratification:

   • APD <10 mm + no caliectasis → Likely physiologic, low intervention risk
   • APD 6-15 mm + diffuse caliectasis → Significantly higher surgical risk (HR 18.7-19.5) compared to APD alone 3
   • APD ≥15 mm → High risk for UPJ obstruction requiring intervention 1

Critical Pitfalls

APD alone has significant limitations 1:

• Does not capture abnormalities of calyces, ureters, or bladder
• Operator-dependent measurement
• Can miss pathology in moderate dilation range

The combination of APD with calyceal assessment is superior to APD alone for predicting surgical intervention 3. For example, an APD of 9-15 mm with diffuse caliectasis carries an 18-fold higher risk of surgery compared to APD measurement alone in that range.

Age-related considerations: APD increases with age (approximately 3.5-3.9% per year) and bladder distention can increase APD by 23-38% 4. Therefore, bladder filling status should be documented during measurement.

Practical Recommendations

For moderate hydronephrosis (APD 10-15 mm): The presence or absence of diffuse caliectasis is the critical discriminator - those with diffuse caliectasis have similar surgical risk to higher grades and warrant closer monitoring 3.

For distal ureteral dilation ≥7 mm: This specific finding increases UTI risk and may warrant consideration of prophylactic antibiotics in high-risk patients 1.

Follow-up timing: Serial imaging is indicated for UTD P2/P3, with functional imaging (MAG3 renal scan) reserved for those at increased risk based on APD thresholds and associated findings 1.